← Back
Data updated: Mar 10, 2026
IMPAX PHARMS
Cardiovascular
IMPAX PHARMS is a generic drug manufacturer focused on Cardiovascular.
2000
Since
7
Drugs
-
Trials
112
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (4)
Company Info
- First Approval
- 2000-11-07
- Latest
- 2024-06-12
- Applications
- 7